Nasdaq: BCAX
Bicara Therapeutics insiders
The officers, directors and 10% owners of Bicara Therapeutics Inc. who hold the most stock, valued at the live BCAX price.
$9.12
BCAX today −$260K (−2.77%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 1
- Their BCAX stock
- $5.2M
- Market value
- $605M
- Held by ranked insiders
- 0.85%
Insiders by value of BCAX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Kiran Mazumdar-Shaw | Director | 565,162 | $5.2M | 0.85% | 14155th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Bicara Therapeutics; see each profile for the filing.